The 7th Annual Post-Approval Summit
May 10-11, 2011
Conference Center at Harvard Medical - Boston,
MA
Three Weeks to the Post-Approval Summit!
The 7th Annual Post-Approval Summit will present sessions on
patient registries in the age of comparative effectiveness. Key CER topics to be covered include:
- The evolution of CER at the National Institutes of Health (NIH).
- NICE guidance on health technology assessment for market access and reimbursement in the United Kingdom.
- Methodological challenges in comparative effectiveness studies.
- Perspectives on using CER data from industry, pharmacy benefits management, and consumer health.
- Evaluating the effectiveness of real-world treatments.
Confirmed speakers represent AHRQ, European Medicines Agency,
NHLBI, NICE, Canadian Institutes of Health Research, Consumers Union, Celgene, Janssen-Ortho, King Pharmaceuticals,
Medtronic, Merck, Takeda, Academy of Ophthalmology, American Society of Clinical Oncology, American Society of Plastic Surgeons,
Harvard Medical School, CVS Caremark Corporation, and Outcome.
Please visit the Summit website at www.postapproval.org to view the full agenda.
Register online at www.postapproval.org. Your registration includes
all conference materials, breakfast and lunch on both days and admittance to the
opening night reception at Boston's Skywalk Observatory.
We look forward to seeing you in May!
Best Regards,
The Committee for the Post-Approval Summit
+1(617)621-6426
[email protected]
201 Broadway, Box 12, Cambridge, MA 02139 USA
